Differential expression of inflammatory and immune response genes in rams experimentally infected with a rough virulent strain of Brucella ovis

Veterinary Immunology and Immunopathology

Volumn 127, Issue 3-4, 2009, Pages 295-303

  Galindo, Ruth C ^a   Muñoz, Pilar M ^b   de Miguel, María J ^b   Marin, Clara M ^b   Blasco, José M ^b   Gortazar, Christian ^a   Kocan, Katherine M ^c   de la Fuente, José ^a,c  

^a INSTITUTO DE INVESTIGACIÓN EN RECURSOS CINEGÉTICOS IREC CSIC UCLM JCCM   (Spain)

^b Instituto Agroalimentario de Aragón IA2   (Spain)

^c OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

Brucella ovis; Brucellosis; Genomics; Immunity; Microarray; Sheep

Indexed keywords

DESMOGLEIN; EPITHELIAL SODIUM CHANNEL; INTERLEUKIN 18 BINDING PROTEIN; MACROPHAGE MIGRATION INHIBITION FACTOR;

ALPHA CHAIN; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL STRAIN; BRUCELLA OVIS; BRUCELLOSIS; CHRONICITY; CONTROLLED STUDY; DEFENSE MECHANISM; DOWN REGULATION; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; HYBRIDIZATION; IMMUNE RESPONSE; IMMUNE RESPONSE GENE; INFLAMMATION; INFLAMMATORY GENE; INNATE IMMUNITY; MALE; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PHAGOCYTOSIS; RAM (SHEEP); REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ANIMALS; BRUCELLA OVIS; BRUCELLOSIS; GENE EXPRESSION REGULATION; GENES, MHC CLASS II; INFLAMMATION; MALE; SHEEP DISEASES; VIRULENCE;

ANIMALIA; BRUCELLA MELITENSIS BIOVAR OVIS; OVIS; OVIS ARIES;

EID: 58349099000     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2008.10.326     Document Type: Article

References (46)

1. Alton G.G., Jones L.M., Angus R.D., and Verger J.M. Techniques for the Brucellosis Laboratory (1988), INRA, Paris, France
2. Amagai M. Desmoglein as a target in autoimmunity and infection. J. Am. Acad. Dermatol. 48 (2003) 244-252
3. Baranger K., Zani M.L., Chandenier J., Dallet-Choisy S., and Moreau T. The antibacterial and antifungal properties of trappin-2 (pre-elafin) do not depend on its protease inhibitory function. FEBS 275 (2008) 2008-2020
4. Barquero-Calvo E., Chaves-Olarte E., Weiss D.S., Guzmán-Verri C., Chacón-Díaz C., Rucavado A., Moriyón I., and Moreno E. Brucella abortus uses a stealthy strategy to avoid activation of the innate immune system during the onset of infection. PLoS ONE 2 (2007) e631
5. Bergmann S., and Hammerschmidt S. Fibrinolysis and host response in bacterial infections. Thromb. Haemost. 98 (2007) 512-520
6. Billard E., Dornand J., and Gross A. Interaction of Brucella suis and Brucella abortus rough strains with human dendritic cells. Infect. Immun. 75 (2007) 5916-5923
7. Blasco J.M. Brucella ovis. In: Nielsen K., and Duncan J.R. (Eds). Animal Brucellosis (1990), CRC Press Inc., Boca Raton, FL 352-378
8. Blasco J.M., Gamazo C., Winter A.J., Jiménez de Bagués M.P., Marín C., Barberán M., et al. Evaluation of whole cell and subcellular vaccines against Brucella ovis in rams. Vet. Immunol. Immunopathol. 37 (1993) 257-270
9. Boura P., Tsapas G., Kountouras J., and Zaharioudaki E. Interferon-A 2a administration in chronic anergic brucellosis. Hepatogatroenterology 42 (1995) 919-922
10. Bureau J.P., Caravano R., Garelli L., and Lemaire J. Cellular responses to "brucelline INRA" during the experimental brucellosis of the mouse. Immunobiology 179 (1989) 8-16
11. Burgess G.W. Ovine contagious epididymitis: a review. Vet. Microbiol. 7 (1982) 551-575
12. Carlyon J.A., and Fikrig E. Invasion and survival strategies of Anaplasma phagocytophilum. Cell Microbiol. 5 (2003) 743-754
13. Carratelli C.R., Paolillo R., and Rizzo A. Chlamydia pneumoniae stimulates the proliferation of HUVEC through the induction of VEGF by THP-1. Int. J. Immunopharmacol. 7 (2007) 287-294
14. Cereghetti G.M., Negro A., Vinck E., Massimino M.L., Sorgato M.C., and Van Doorslaer S. Copper (II) binding to the human Doppel protein may mark its functional diversity from the prion protein. J. Biol. Chem. 279 (2004) 36497-36503
15. Chromek M., Slamova Z., Bergman P., Kovacs L., Podracka L., Ehren I., Hokfelt T., Gudmundsson G.H., Gallo R.L., Agerberth B., and Brauner A. The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat. Med. 12 (2006) 636-641
16. Cutler S.J., Whatmore A.M., and Commander A.J. Burecellosis, new aspects of an old disease. J. Appl. Microbiol. 98 (2005) 1270-1281
17. Ding X.Z., Fernandez-Prada C.M., Bhattacharjee A.K., and Hoover D.L. Over-expression of hsp-70 inhibits bacterial lipopolysaccharide-induced production of cytokines in human monocyte-derived macrophages. Cytokine 16 (2001) 210-219
18. Eskra L., Mathison A., and Splitter G. Microarray analysis of mRNA levels from RAW264.7 macrophages infected with Brucella abortus. Infect. Immun. 71 (2003) 1125-1133
19. Fernández de Mera I.G., Pérez de la Lastra J.M., Ayoubi P., Naranjo V., Kocan K.M., Gortazar C., and de la Fuente J. Differential expression of inflammatory and immune response genes in mesenteric lymph nodes of Iberian red deer (Cervus elaphus hispanicus) naturally infected with Mycobacterium bovis. Dev. Comp. Immunol. 32 (2008) 85-91
20. Foster G., Osterman B.S., Godfroid J., Jacques I., and Cloeckaert A. Brucella ceti sp. nov. and Brucella pinnipedialis sp. nov. for Brucella strains with cetaceans and seals as their preferred hosts. Int. J. Syst. Evol. Microbiol. 57 (2007) 2688-2693
21. Galindo R.C., Ayoubi P., García-Pérez A.L., Naranjo V., Kocan K.M., Gortazar C., and de la Fuente J. Differential expression of inflammatory and immune response genes in sheep infected with Anaplasma phagocytophilum. Vet. Immun. Immunopathol 126 (2008) 27-34
22. Gonzalez-Mariscal L., Betanzos A., Nava P., and Jaramillo B.E. Tight junction proteins. Prog. Biophys. Mol. Biol. 81 (2003) 1-44
23. He Y., Reichow S., Ramamoorthy S., Ding X., Lathigra R., Craig J., Sobral B., Schurig G., Sriranganathan N., and Boyle S. Brucella melitensis triggers time-dependent modulation of apoptosis and down-regulation of mitochondrion-associated gene expression in mouse macrophages. Infect. Immun. 74 (2006) 5035-5046
24. Jasti J., Furukawa H., Gonzales E.B., and Gouaux E. Structure of acid-sensing ion channel 1 at 1.9 Å resolution and low pH. Nature 449 (2007) 316-322
25. Jiménez de Bagüés M.P., Terraza A., Gross A., and Dornand J. Different responses of macrophages to smooth and rough Brucella spp: relationship to virulence. Infect. Immun. 72 (2004) 2429-2433
26. Kusumawati A., Cazevieille C., Porte F., Bettache S., Liautard J.P., and Sri Widada J. Early events and implication of F-actin and annexin I associated structures in the phagocytic uptake of Brucella suis by the J-774A.1 murine cell line and human monocytes. Microb. Pathogen. 28 (2000) 343-352
27. Koul A., Herget T., Klebl B., and Ullrich A. Interplay between mycobacteria and host signalling pathways. Nat. Rev. Microbiol. 2 (2004) 189-202
28. Lamontagne J., Butler H., Chaves-Olarte E., Hunter J., Schirm M., Paquet C., Tian M., Kearney P., Hamaidi L., Chelsky D., Moriyón I., Moreno E., and Paramithiotis E. Extensive cell envelope modulation is associated with virulence in Brucella abortus. J. Proteome Res. 6 (2007) 1519-1529
29. Mannonen L., Nikula T., Haveri A., Reinikainen A., Vuola J.M., Lahesmaa R., and Puolakkainen M. Up-regulation of host cell genes during interferon-gamma-induced persistent Chlamydia pneumoniae infection in HL cells. J. Infect. Dis. 195 (2007) 212-219
30. Marín C.M., Jimenez de Bagüés M.P., Barberán M., and Blasco J.M. Comparison of two selective media for the isolation of Brucella melitensis from naturally infected sheep and goats. Vet. Rec. 138 (1996) 409-411
31. Mora A.L., Torres-González E., Rojas M., Corredor C., Ritzenthaler J., Xu J., Roman J., Brigham K., and Stecenko A. Activation of alveolar macrophages via the alternative pathway in herpesvirus-induced lung fibrosis. Am. J. Respir. Cell Mol. Biol. 35 (2006) 466-473
32. Moreno E., and Gorvel J.P. Invasion, intracellular trafficking and replication of Brucella organisms in professional and nonprofessional phagocytes. In: Lopes-Goni I., and Moriyon I. (Eds). Brucella Molecular and Cellular Biology (2004), Horizon Bioscience, Wymondham, UK 287-312
33. Naranjo V., Villar M., Martín-Hernando M.P., Vidal D., Höfle U., Gortazar C., Kocan K.M., Vázquez J., and de la Fuente J. Proteomic and transcriptomic analyses of differential stress/inflammatory responses in mandibular lymph nodes and oropharyngeal tonsils of European wild boars naturally infected with Mycobacterium bovis. Proteomics 7 (2007) 220-231
34. Nau G.J., Richmond J.F., Schlesinger A., Jennings E.G., Lander E.S., and Young R.A. Human macrophage activation programs induced by bacterial pathogens. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 1503-1508
35. Ohnemus U., Kohrmeyer K., Houdek P., Rohde H., Wladykowski E., Vidal S., Horstkotte M.A., Aepfelbacher M., Kirschner N., Behne M.J., Moll I., and Brandner J.M. Regulation of epidermal tight-junctions (TJ) during infection with exfoliative toxin-negative Staphylococcus strains. J. Invest. Dermatol. 128 (2008) 906-916
36. Paolicchi F.A., Terzolo H.R., and Campero C.M. Isolation of Brucella suis from the semen of a ram. Vet. Rec. 132 (1993) 67
37. Rafiei A., Ardestani S.K., Kariminia A., Keyhani A., Mohraz M., and Amirkhani A. Dominant Th1 cytokine production in early onset of human brucellosis followed by switching towards Th2 along prolongation of disease. J. Infect. 53 (2006) 315-324
38. Rajashekara G., Eskra L., Mathison A., Petersen E., Qiqi Y., Harms J., and Splitter G. Brucella: functional genomics and host-pathogen interactions. Anim. Health Res. Rev. 7 (2006) 1-11
39. Roop II M.R., Bellaire B.H., Wrigh M.V., and Cardelli J.A. Adaptation of the brucellae to their intracellular niche. Mol. Microbiol. 52 (2004) 621-630
40. Sato F., Imaizumi T., Sashinami H., Yoshida H., Kusumi T., Mori F., Wakabayashi K., Nakane A., Satoh K., and Kijima H. Upregulation of vascular endothelial growth factor by heat-killed Listeria monocytogenes in macrophages. Biochem. Biophys. Res. Commun. 354 (2007) 608-612
41. Schalkwijk J., Wiedow O., and Hirose S. The trappin gene family: proteins defined by an N-terminal transglutaminase substrate domain and a C-terminal four-disulphide core. Biochem. J. 340 (1999) 569-577
42. Takatsu K. Interleukin 5 and B cell differentiation. Cytokine Growth Factor Rev. 9 (1998) 25-35
43. Tsitsikov E.N., Laouini D., Dunn I.F., Sannikova T.Y., Davidson L., Alt F.W., and Geha R.S. TRAF1 is a negative regulator of TNF signaling: enhanced TNF signaling in TRAF1-deficient mice. Immunity 15 (2001) 647-657
44. Vendrame C.M., Carvalho M.D., Rios F.J., Manuli E.R., Petitto-Assis F., and Goto H. Effect of insulin-like growth factor-I on Leishmania amazonensis promastigote arginase activation and reciprocal inhibition of NOS2 pathway in macrophage in vitro. Scand. J. Immunol. 66 (2007) 287-296
45. Xu H., and Chu S. ENaC alpha-subunit variants are expressed in lung epithelial cells and are suppressed by oxidative stress. Am. J. Physiol. Lung Cell Mol. Physiol. 293 (2007) 454-462
46. Yamada G., Shijubo N., Takagi-Takahashi Y., Nishihira J., Mizue Y., Kikuchi K., and Abe S. Elevated levels of serum macrophage migration inhibitory factor in patients with pulmonary tuberculosis. Clin. Immunol. 104 (2002) 123-127